Japan OKs 1st iPS Regenerative Medicine for Insurance Coverage
Tokyo, May 13 (Jiji Press)–A Japanese health ministry council on Wednesday approved the public health insurance coverage for a regenerative medicine for Parkinson’s disease produced from induced pluripotent stem, or iPS, cells, effective from May 20. With the approval by the Central